Many provider groups and product manufacturers recognize the inherent value of validated, well-structured datasets generated in the busy clinical setting.  (The FDA, payers and others refer to such datasets as real-world evidence.)  A major category of thoughtfully-designed and executed real-world evidence programs is intellectual property – inventions, patents, trade secrets, and copyrights.

Most large hospital systems now have “innovation centers”, “tech transfer departments” and similar units designed to generate license revenues.  They generally fail, however, to tap into RWE, the richest source of such IP.  Moreover, their revenue shares for clinician inventors, and complex IP processes, may often stifle rather than incentivize marketable inventions.

Meanwhile, independent practice groups are now in an equally strong position to develop and capture IP value through real-world evidence programs.  They can do so on their own, accumulating and curating fit-for-purpose RWE until its clinical significance warrants licensing and monetization.  Alternatively, they can partner with product manufacturers in establishing an RWE program designed to maximize specific IP objectives from the beginning.

In all cases, Circles represent a robust yet low-cost platform, with excellent user experience, for designing and implementing RWE programs leading to IP value.

Contact us to learn more.